Cardiac asthma--its origin, recognition and management.
Bronchospasm due to cardiac disease results from increased pulmonary capillary pressure and impaired lymphatic drainage. Bronchospasm can usually be attributed to cardiac disease if physical and roentgenographic examination support the diagnosis of cardiac failure. The latter is especially helpful in revealing interstitial edema and redistribution of blood flow to the upper lobes. Therapy is directed at decreasing lung water, improving gas exchange and searching for the underlying mechanism of cardiac failure.
D000403:Airway Resistance; D000628:Aminophylline / Q000627:therapeutic use; D000818:Animals; D001986:Bronchial Spasm / Q000150:complications / Q000209:etiology*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D004418:Dyspnea, Paroxysmal / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D009020:Morphine / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010808:Physical Examination; D011654:Pulmonary Edema / Q000209:etiology
D004071:Digitalis Glycosides; D004232:Diuretics; D009599:Nitroprusside; D000628:Aminophylline; D009020:Morphine; D005996:Nitroglycerin